What Causes Heart Palpitations with Fibroids?

What Causes Heart Palpitations with Fibroids?

Yes, fibroids can directly cause heart palpitations — and the most common mechanism is iron-deficiency anemia driven by chronic heavy menstrual bleeding. A compensating heart rate is the body's attempt to deliver oxygen when hemoglobin is low. Hormonal imbalance, magnesium depletion, and autonomic nervous system dysregulation are secondary pathways. The exception: palpitations in the absence of anemia or hormonal disruption warrant independent cardiac evaluation.

---

Why Fibroids Disrupt More Than Just Your Uterus

Uterine fibroids — benign smooth muscle tumors that affect an estimated 70–80% of women by age 50 (Stewart et al., American Journal of Obstetrics and Gynecology 2017; PMID: 27986379) — are rarely thought of as a cardiovascular issue. But their downstream consequences reach the heart through several well-documented pathways.

The most direct path is blood loss. Submucosal and intramural fibroids frequently distort the uterine cavity and disrupt normal hemostasis, causing menorrhagia (heavy menstrual bleeding). When monthly losses are severe enough, the body cannot replenish red blood cells fast enough, and iron stores collapse. The result is iron-deficiency anemia — and an anemic heart must compensate by beating faster and harder to maintain oxygen delivery to tissues.

This compensatory tachycardia is often perceived as palpitations: a racing heart, skipped beats, or a fluttering sensation in the chest. The same phenomenon explains what causes heart palpitations during a heavy period, a closely related presentation that shares anemia as its central driver.

---

The Anemia–Palpitation Connection: Biomarkers That Matter

Not all anemia looks the same, and fibroid-related anemia has a specific fingerprint. Here are the key markers to test:

Ferritin is the critical early marker. Research shows that ferritin can fall into a symptomatic range — causing fatigue, breathlessness, and tachycardia — weeks before hemoglobin formally dips below anemia thresholds (Soppi, Clinical Case Reports 2018; PMID: 30062004). Testing hemoglobin alone misses a significant portion of fibroid patients who are functionally iron-depleted.

For a deeper look at why potassium can also become depleted alongside iron in heavy-bleeding scenarios, the article on potassium deficiency causes and tests covers the relevant electrolyte disruptions.

---

Estrogen Dominance: The Hormonal Pathway to Palpitations

Fibroids are estrogen-sensitive tumors. They grow in response to estrogen and tend to shrink after menopause when estrogen drops. This bidirectional relationship means women with symptomatic fibroids often have a degree of estrogen dominance — a state in which estrogen is elevated relative to progesterone, regardless of absolute levels.

Elevated estrogen has direct cardiovascular effects. Beta-adrenergic receptors in the heart are modulated by estrogen; excess estrogen can increase receptor sensitivity, raising resting heart rate and promoting ectopic beats (Mendelsohn & Karas, New England Journal of Medicine 1999; PMID: 10202168). More acutely, fluctuating estrogen levels — as seen in the luteal phase or around fibroid-related hormonal spikes — can activate the sympathetic nervous system and trigger the perception of palpitations.

This same mechanism is at work in other hormonal contexts. Heart palpitations in PCOS, for example, involve androgen-to-estrogen imbalances that similarly sensitize the cardiac autonomic response. And heart palpitations in PMDD reflect exaggerated CNS sensitivity to progesterone metabolites — a different hormonal trigger, but the same autonomic endpoint.

Progesterone, when adequate, counterbalances estrogen at the receptor level and has a calming effect on the sympathetic nervous system. Women with fibroids frequently have relatively low progesterone in the luteal phase, which removes that buffer and leaves the autonomic nervous system more reactive.

---

Magnesium Depletion: The Overlooked Electrolyte Link

Fibroid-related heavy bleeding depletes more than iron. Magnesium — the electrolyte most closely tied to cardiac rhythm — is lost during menstruation and is frequently deficient in women with hormonally driven conditions.

Magnesium stabilizes cardiac ion channels. It regulates the Na⁺/K⁺-ATPase pump and helps maintain normal sinus rhythm by moderating calcium influx into myocardial cells. When magnesium falls, the threshold for ectopic beats lowers, and palpitations become more likely. A meta-analysis in the journal Nutrients confirmed that magnesium supplementation significantly reduced the frequency of cardiac arrhythmias in deficient patients (Workinger et al., Nutrients 2018; PMID: 30200431).

Estrogen dominance compounds this. Estrogen promotes intracellular magnesium uptake into soft tissue, paradoxically reducing freely available serum magnesium. The combination of menstrual loss and estrogen-driven redistribution creates a perfect environment for both dysrhythmias and heightened stress reactivity — explaining why fibroid flares often coincide with the worst palpitation episodes.

Checking a red blood cell (RBC) magnesium level rather than serum magnesium gives a more accurate picture of intracellular status, which is where the electrolyte actually exerts its cardiac effects.

---

Stress, the Autonomic Nervous System, and Fibroid Flares

Chronic pelvic pain, sleep disruption, and the psychological burden of managing a chronic condition all activate the hypothalamic-pituitary-adrenal (HPA) axis. Elevated cortisol raises resting heart rate, increases vascular tone, and sensitizes adrenergic receptors — all of which lower the threshold for perceived palpitations.

There is also a direct cortisol–fibroid interaction: cortisol competes with progesterone at shared receptor sites (the glucocorticoid and progesterone receptors share significant structural homology), which can worsen the relative progesterone deficiency that already exists in fibroid patients. This hormonal crosstalk links everyday stress directly into the fibroid–palpitation cycle.

The autonomic nervous system component is underappreciated in clinical practice. Research using heart rate variability (HRV) monitoring has found that women with chronic pain conditions — including those with significant uterine pathology — show measurably reduced parasympathetic tone (Thayer et al., Neuroscience & Biobehavioral Reviews 2012; PMID: 21872616). Lower HRV means less autonomic flexibility, making the heart more prone to reactive rate changes that register as palpitations.

Wearable devices that track HRV can identify these patterns before you consciously notice them, which is one reason real-time biosensor data is increasingly useful for personalizing supplementation and lifestyle interventions.

---

Thyroid Involvement: When Fibroids and Hypothyroidism Overlap

Hypothyroidism and uterine fibroids frequently co-occur. Both conditions are linked to estrogen dominance, and both produce heavy menstrual bleeding — meaning they compound each other's contribution to anemia and palpitations.

Subclinical hypothyroidism (TSH elevated but still within broad lab ranges) can produce palpitations through two mechanisms: bradycardia can paradoxically trigger compensatory ectopic beats, and thyroid hormone directly regulates cardiac contractility. When thyroid function is low and anemia is present simultaneously, the cardiac stress is additive.

If you experience palpitations alongside cold intolerance, hair thinning, or unexplained weight gain on top of fibroid symptoms, a full thyroid panel — TSH, Free T3, Free T4, and thyroid antibodies — is warranted. The connection between thyroid dysfunction and palpitations is explored in more depth in the context of heart palpitations in perimenopause with hypothyroidism, where estrogen decline adds another variable to an already complex hormonal picture.

---

From Symptom to Protocol: What to Test and When

A symptom-first approach to fibroid-related palpitations works through three tiers:

Tier 1 — Confirm or rule out anemia:

1. Order a complete blood count (CBC) with differential.
2. Add serum ferritin (not just iron saturation).
3. Add RBC magnesium.
4. Review results against optimal — not just lab reference — ranges.

Tier 2 — Assess hormonal drivers:

1. Serum estradiol and progesterone (timed to luteal phase, day 19–22).
2. SHBG (sex hormone binding globulin) — low SHBG increases free estrogen exposure.
3. TSH, Free T3, Free T4 if thyroid symptoms are present.
4. Morning cortisol or a 4-point salivary cortisol test if HPA dysregulation is suspected.

Tier 3 — Cardiac evaluation if indicated:

1. Resting ECG to rule out structural or rhythm abnormalities.
2. 24–48 hour Holter monitor if episodes are frequent.
3. Echocardiogram if murmur or structural concern exists.

This sequence ensures you're not treating palpitations as a primary cardiac event when the real driver is upstream — in the uterus, the bloodstream, or the endocrine system.

---

What This Means for Your Formula

Because fibroid-related palpitations arise from multiple overlapping pathways, no single supplement addresses them. Ones — a personalized supplement platform that analyzes blood work, wearable data, and health history — builds formulas that target each identified deficiency rather than applying a generic women's health stack.

For fibroid patients with confirmed iron-deficiency anemia, Ones can incorporate targeted iron-supportive co-factors (vitamin C for absorption enhancement, B12, and folate) depending on the individual's full panel. The goal is optimizing erythropoiesis — red blood cell production — not simply replacing iron in isolation.

For the estrogen-dominance and autonomic components, Ones includes Magnesium Glycinate at clinically meaningful doses — the glycinate form is absorbed more efficiently and crosses the blood-brain barrier to support both cardiac rhythm and the parasympathetic nervous system. Where HPA-axis involvement is flagged by cortisol data or HRV trends, Ashwagandha KSM-66 at 600mg is a validated adaptogen shown to reduce cortisol by 27.9% in stressed adults over 60 days (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798). For women where thyroid co-involvement is identified, the Ones Thyroid Support blend addresses iodine, selenium, and zinc needs at evidence-matched doses.

Because the formula is built from lab data — not from a questionnaire — the capsule count and ingredient selection reflect your actual physiology, not an average.

---

Key Takeaways

• Anemia is the primary culprit. Heavy menstrual bleeding from fibroids depletes iron and forces compensatory cardiac output, which registers as palpitations.
• Ferritin, not just hemoglobin, is the biomarker to test. Functional iron deficiency produces symptoms well before formal anemia criteria are met.
• Estrogen dominance sensitizes the cardiac autonomic system. Estrogen modulates beta-adrenergic receptors; relative progesterone deficiency removes the buffer.
• Magnesium depletion lowers the threshold for ectopic beats. Blood loss and estrogen-driven redistribution both deplete magnesium — check RBC magnesium, not serum.
• Chronic stress and HPA activation compound the problem. Cortisol competes with progesterone at receptor sites, worsening the hormonal imbalance driving palpitations.
• Always rule out thyroid involvement. Fibroids and hypothyroidism co-occur frequently, and both conditions contribute to heavy bleeding, anemia, and dysrhythmia risk.

---

This article is for informational purposes only and does not constitute medical advice. Palpitations can have serious cardiac causes. Consult a qualified healthcare provider before starting any supplement protocol or if your symptoms are new, severe, or accompanied by chest pain or fainting.